ORTOMEDIC AS

1366 LYSAKER

Finances

Share Ownership

Return on Equity

17,19 %

Current Ratio

2,33

Debt-to-Equity Ratio

0,04

Key figures (NOK)	2022	2021	2020	2019
Revenue	510 062 000	481 744 000	476 195 000	397 022 000
Net Income	27 969 000	26 504 000	25 767 000	16 602 000
Total Assets	293 381 000	254 897 000	229 987 000	254 224 000
Total Equity	162 666 000	144 972 000	129 124 000	107 400 000

Income (NOK)	2022	2021	2020	2019
Revenue	510 062 000	481 744 000	476 195 000	397 022 000
Expenditure	472 198 000	447 205 000	442 119 000	373 985 000
Operating Profit	37 864 000	34 540 000	34 076 000	23 036 000
Financial Income	1 243 000	1 318 000	2 004 000	340 000
Financial Costs	2 937 000	1 676 000	2 891 000	1 894 000
Financial Balance	−1 694 000	−358 000	−887 000	−1 554 000
Earnings Before Tax	36 170 000	34 182 000	33 189 000	21 482 000
Tax	8 202 000	7 678 000	7 422 000	4 880 000
Net Income	27 969 000	26 504 000	25 767 000	16 602 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	5 668 000	6 551 000	5 347 000	4 817 000
Total Current Assets	287 713 000	248 346 000	224 640 000	249 407 000
Total Assets	293 381 000	254 897 000	229 987 000	254 224 000
Total Retained Equity	158 516 000	140 822 000	124 974 000	103 250 000
Total Equity	162 666 000	144 972 000	129 124 000	107 400 000
Total Long-Term Debt	6 976 000	7 498 000	7 265 000	6 892 000
Total Current Debt	123 739 000	102 427 000	93 598 000	139 933 000
Total Equity and Debt	293 381 000	254 897 000	229 987 000	254 224 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	510 062 000	481 692 000	475 872 000	397 022 000
Other Income	0	52 000	323 000	0
Revenue	510 062 000	481 744 000	476 195 000	397 022 000
Cost of Goods Sold	343 238 000	336 691 000	341 882 000	275 878 000
Salary Costs	82 555 000	76 232 000	70 187 000	63 504 000
Depreciation	790 000	800 000	683 000	849 000
Impairment	0	0	0	0
Expenditure	472 198 000	447 205 000	442 119 000	373 985 000
Operating Profit	37 864 000	34 540 000	34 076 000	23 036 000
Financial Income	1 243 000	1 318 000	2 004 000	340 000
Financial Costs	2 937 000	1 676 000	2 891 000	1 894 000
Financial Balance	−1 694 000	−358 000	−887 000	−1 554 000
Dividends	0	0	0	0
Net Income	27 969 000	26 504 000	25 767 000	16 602 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	3 168 000	4 294 000	3 092 000	2 458 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	2 133 000	1 690 000	1 755 000	2 359 000
Total Tangible Assets	2 133 000	1 690 000	1 755 000	2 359 000
Total Fiancial Fixed Assets	367 000	567 000	500 000	0
Total Fixed Assets	5 668 000	6 551 000	5 347 000	4 817 000
Stock	179 854 000	156 198 000	148 162 000	156 283 000
Total Investments	0	0	0	0
Cash, Bank	4 913 000	23 989 000	11 651 000	12 582 000
Total Current Assets	287 713 000	248 346 000	224 640 000	249 407 000
Total Assets	293 381 000	254 897 000	229 987 000	254 224 000
Total Equity	162 666 000	144 972 000	129 124 000	107 400 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	6 976 000	7 498 000	7 265 000	6 892 000
Creditors	77 804 000	63 594 000	42 692 000	110 784 000
Unpaid Taxes	13 761 000	15 786 000	16 673 000	18 714 000
Dividends	0	0	0	0
Other Current Debt	11 494 000	9 260 000	6 847 000	6 558 000
Total Current Debt	123 739 000	102 427 000	93 598 000	139 933 000
Total Equity and Debt	293 381 000	254 897 000	229 987 000	254 224 000

Financial indicators	2022	2021	2020	2019
Return on Equity	17,19 %	18,28 %	19,96 %	15,46 %
Debt-to-Equity Ratio	0,04	0,05	0,06	0,06
Operating Profit Margin	7,42 %	7,17 %	7,16 %	5,8 %
Current Ratio	2,33	2,42	2,4	1,78
Quick Ratio	−5,13	−4,62	−4,12	−15,25
Equity Ratio	0,55	0,57	0,56	0,42
Gross Profit Margin	32,71 %	30,11 %	28,21 %	30,51 %